Results 41 to 50 of about 1,696 (185)
Annals of Pediatric Cardiology, 2022 A 6-month-old boy, a case of Shone's complex, presented in decompensated state was found to have severe mitral stenosis along with multisystem inflammatory syndrome in children (MISC) warranting urgent surgical intervention.
Anil Kumar +4 more
doaj +1 more source
Severe Clozapine Poisoning Treated by Extracorporeal Blood Purification Therapy
Case Reports in Nephrology and Dialysis, 2023 Clozapine is a frequently used antipsychotic that, in case of overdose, can cause severe adverse side effects, such as hematological, cardiovascular, and neurological complications.
Andreas Hartjes +3 more
doaj +1 more source
Pancreatitis cytosorbents (CytoSorb) inflammatory cytokine removal
Medicine, 2019 Abstract Background: Acute pancreatitis (AP) usually has a mild course with a mortality rate below 1%. However, around 10% of patients develop severe AP (SAP) involving extra-pancreatic tissues and other organ systems. The mortality of SAP is around 42%.
Huber, Wolfgang +6 more
openaire +2 more sources
Biomedicines, 2022 Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce.
Janina Praxenthaler +6 more
doaj +1 more source
, 2023 Die generalisierte Inflammationsreaktion, die im Rahmen des Leberversagens vorkommen kann, führt im äußersten Fall zu multiplem Organversagen.
Reitmeier, Valerie
core +1 more source
CytoSorb use in critically ill patients with hyperbilirubinemia
, 2021 CytoSorb, a relatively new blood purification technique is gaining popularity with different indications in critically ill patients. Our aim is to summarize currently available data on CytoSorb use in critically ill patients with acquired hepatic injury ...
Klementina Ocskay
core +1 more source
Efficacy of CytoSorb® - A Metaanalysis
, 2022 Abstract Cytokine adsorption using the CytoSorb® device has been proposed in various clinical settings including sepsis, ARDS, hyperinflammatory syndromes, cardiac surgery or recovery after cardiac arrest. The aim of this analysis is to provide evidence for the efficacy of the CytoSorb® device with regard to mortality in various settings ...
Sören Becker +5 more
openaire +1 more source
Pharmacology Research & Perspectives, 2021 Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including ...
Paul Biever +7 more
doaj +1 more source
Table1_Impact of CytoSorb® on interleukin-6 in cardiac surgery.pdf
, 2023 ObjectiveCardiac surgery is known to activate a cascade of inflammatory mediators leading to a systemic inflammatory response. Hemadsorption (HA) devices such as CytoSorb® have been postulated to mitigate an overshooting immune response, which is ...
Daniela Geisler (16902909) +15 more
core +1 more source
CytoSorb® usage in a dual antiplatelet agent treated patient during CABG and broken guidewire retrieval from right coronary artery ostium [PDF]
International Journal of Medical Device and Adjuvant Treatments, 2022 Objective: We report a case of a patient undergoing Open Coronary Artery Bypass Graft Surgery (CABG) with CytoSorb® under dual antiplatelet therapy (DAPT) with a broken guidewire in RCA ostium.
N. Kumar, V. Keshri, R. Bhuyan
doaj +1 more source